These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 16499663

  • 21. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
    Lin SW, Ke FC, Hsiao PW, Lee PP, Lee MT, Hwang JJ.
    Exp Cell Res; 2007 Feb 01; 313(3):602-13. PubMed ID: 17187779
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Protein tyrosine kinase inhibitor genistein suppresses in vitro invasion of HT1080 human fibrosarcoma cells].
    Yan C, Han R.
    Zhonghua Zhong Liu Za Zhi; 1999 May 01; 21(3):171-4. PubMed ID: 11776827
    [Abstract] [Full Text] [Related]

  • 25. Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
    Helenius MA, Savinainen KJ, Bova GS, Visakorpi T.
    BJU Int; 2006 Feb 01; 97(2):404-9. PubMed ID: 16430655
    [Abstract] [Full Text] [Related]

  • 26. Inhibitors of urokinase reduce size of prostate cancer xenografts in severe combined immunodeficient mice.
    Jankun J, Keck RW, Skrzypczak-Jankun E, Swiercz R.
    Cancer Res; 1997 Feb 15; 57(4):559-63. PubMed ID: 9044824
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
    Tiberio A, Farina AR, Tacconelli A, Cappabianca L, Gulino A, Mackay AR.
    Int J Cancer; 1997 Nov 27; 73(5):740-8. PubMed ID: 9398056
    [Abstract] [Full Text] [Related]

  • 34. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.
    Cancer Res; 2007 Jan 01; 67(1):9-15. PubMed ID: 17210677
    [Abstract] [Full Text] [Related]

  • 35. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A, Xue M, Jackson C, Smith RC.
    Int J Biochem Cell Biol; 2009 Jan 01; 41(8-9):1731-8. PubMed ID: 19433314
    [Abstract] [Full Text] [Related]

  • 36. Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF-[kappa]B by the new synthesized ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxylate (JOTO1007) in human cervical cancer Ca ski cells.
    Huang AC, Hsu SC, Kuo CL, Liao CL, Lai KC, Lin TP, Wu SH, Lu HF, Tang NY, Yang JS, Chung JG.
    In Vivo; 2009 Jan 01; 23(4):613-9. PubMed ID: 19567397
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.
    Int J Mol Med; 2006 Nov 01; 18(5):941-50. PubMed ID: 17016625
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.